Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul:285:105844.
doi: 10.1016/j.tvjl.2022.105844. Epub 2022 May 28.

Visualising the endothelial glycocalyx in dogs

Affiliations

Visualising the endothelial glycocalyx in dogs

Sara J Lawrence-Mills et al. Vet J. 2022 Jul.

Abstract

The endothelial glycocalyx (eGlx) lines the luminal surface of endothelial cells. It is critical in maintaining vascular health and when damaged contributes to many diseases. Its fragility makes studying the eGlx technically challenging. The current reference standard for eGlx visualisation, by electron microscopy using glutaraldehyde/Alcian blue perfusion fixation, has not been previously reported in dogs. Established techniques were applied to achieve visualisation of the eGlx in the microvasculature of reproductive tissue in five healthy dogs undergoing elective neutering. Uterine and testicular artery samples underwent perfusion fixation, in the presence of Alcian blue, prior to transmission electron microscopy imaging. Image processing software was used to determine eGlx depth. EGlx was visualised in the arteries of two dogs, one testicular and one uterine, with median (range) eGlx depths of 68.2 nm (32.1-122.9 nm) and 47.6 nm (26.1-129.4 nm) respectively. Study of the eGlx is technically challenging, particularly its direct visualisation in clinical samples. Further research is needed to develop more clinically applicable techniques to measure eGlx health.

Keywords: Alcian blue; Canine; Microvasculature; Transmission electron microscopy.

PubMed Disclaimer

Conflict of interest statement

MSD provided a financial award to Sara Lawrence-Mills (nee Hillyer) to support her presentation of the research at the British Small Animal Veterinary Association Congress 2018 and the Southern European Veterinary Conference 2018. None of the authors has any other financial or personal relationships that could inappropriately influence or bias the content of the paper.

Figures

Fig. 1
Fig. 1
These images depict the process of perfusing a uterine artery sample prior to processing for TEM. A) Uterine horn with uterine artery labelled. B) Following perfusion with glucose-free mammalian Ringer-Locke’s solution to remove plasma proteins and red blood cells. C) After perfusion with Alcian blue fixative solution. OV, ovary; UA, uterine artery; UH, uterine horn.
Fig. 2
Fig. 2
Front and side views of the equipment used to achieve Alcian blue perfusion and fixation for endothelial glycocalyx visualisation. Two 50 ml Falcon tube reservoirs were used as Alcian blue storage chambers (one flush, one fixative). These were attached via taps to a Y connector and a catheter. Controlled perfusion pressure was applied via an air pressure reservoir, the positive pressure chamber comprising a 500 ml plastic bottle maintained at 100 mmHg by a sphygmomanometer bulb. The reservoir taps allowed selection of either flush or fix reservoir via the Alcian blue perfusion pipes to the catheter.
Fig. 3
Fig. 3
Transmission electron microscopy images of dog endothelial glycocalyx. A) Lower and B) Higher power images of dog uterine artery (NB: different sections are shown). C) Higher power image of dog testicular artery. EC, endothelial cell; eGlx, endothelial glycocalyx; RBC, red blood cell; VL, vessel lumen.

References

    1. Alphonsus C.S., Rodseth R.N. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69:777–784. - PubMed
    1. Brands J., Hubel C.A., Althouse A., Reis S.E., Pacella J.J. Noninvasive sublingual microvascular imaging reveals sex-specific reduction in glycocalyx barrier properties in patients with coronary artery disease. Physiolology Reports. 2020;8 - PMC - PubMed
    1. Broekhuizen L.N., Mooij H.L., Kastelein J.J., Stroes E.S., Vink H., Nieuwdorp M. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Current Opinion in Lipidology. 2009;20:57–62. - PubMed
    1. Chevalier L., Selim J., Genty D., Baste J.M., Piton N., Boukhalfa I., Hamzaoui M., Pareige P., Richard V. Electron microscopy approach for the visualization of the epithelial and endothelial glycocalyx. Official journal of French Association of Morphologists. 2017;101:55–63. - PubMed
    1. Constantinescu A., Spaan J.A., Arkenbout E.K., Vink H., Vanteeffelen J.W. Degradation of the endothelial glycocalyx is associated with chylomicron leakage in mouse cremaster muscle microcirculation. Journal of Thrombosis and Haemostasis. 2011;105:790–801. - PubMed

LinkOut - more resources